Current Cancer Drug Targets

Papers
(The median citation count of Current Cancer Drug Targets is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
A Pilot Study of Anlotinib as a Combination Treatment in Advanced Nasopharyngeal Carcinoma49
Case Report and Literature Review of Multi-drugs Synergy and Targeted Comprehensive Treatment in Advanced Hepatocellular Carcinoma27
Experimental Determination of Cancer Drug Targets with Independent Mechanisms of Resistance26
Artificial Intelligence (AI) and Liquid Biopsy Transforming Early Detection of Liver Metastases in Gastrointestinal Cancers24
Engineering Pancreatic Organoids22
Efficacy and Safety of Immunotherapy Combined with Anlotinib as FirstLine Treatment in Older NSCLC Patients with PD-L1 Expression<50%22
TCF19 Enhances Glioma Cell Proliferation via Modulating the Β-Catenin Signaling Pathway through Accelerating DHX32 Transcription21
Computational Design for Identification of Human Anti-MUC1 Heteroclitic Peptides in the Treatment of HER2-Positive Breast Cancer through Neural Network Training and Monomeric based Design19
Clinical Significance of HHLA2 as a Novel Therapeutic Target for Colorectal Cancer19
The Plasticity of Circulating Tumor Cells in Ovarian Cancer During Platinum-containing Chemotherapy17
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway16
Gastroenteropancreatic Neuroendocrine Neoplasms (GEP NENs): The Role of Checkpoint Inhibitors15
The Pattern of Anemia in Pediatric Solid Tumors Prior to and after Chemotherapy- A Retrospective Cohort Study15
New Progress on DNA Primase Subunit Enzymes Research and Link to Cancer Development and Treatment Approaches15
Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators14
β-lapachone: A Promising Anticancer Agent with a Unique NQO1 Specific Apoptosis in Pancreatic Cancer12
Dextran Sulfate Inhibits Cell Proliferation and Induces Apoptosis by Regulating EZH2 in Gastric Carcinoma12
PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance12
Combined Transarterial Chemoembolization with Microwave Ablation versus Microwave Alone for Treatment of Medium Sized Hepatocellular Carcinoma11
Investigating the Influence of Gut Microbiota-related Metabolites in Gastrointestinal Cancer11
The Impacts of Non-coding RNAs and N6-Methyladenosine on Cancer: Past, Present and Future10
Repurposing of Antidiarrheal Loperamide for Treating Melanoma by Inducing Cell Apoptosis and Cell Metastasis Suppression In vitro and In vivo9
Immune Checkpoint Inhibitors for Advanced Biliary Tract Cancer9
Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma9
The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers9
Silencing HEATR1 Rescues Cisplatin Resistance of Non-Small Cell Lung Cancer by Inducing Ferroptosis via the p53/SAT1/ALOX15 Axis9
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice9
Deoxypodophyllotoxin Mediates Autophagy Death through Inhibition of GRP78 in Human Osteosarcoma9
Preface9
A Combination Therapy of Cyclophosphamide and Immunomodulating Agents in Cancer8
Bioinformatics and Experimental Study Revealed LINC00982/ miR-183-5p/ABCA8 Axis Suppresses LUAD Progression8
Role of miRNA-99a-5p in Modulating the Function of Hepatocellular Carcinoma Cells: Bioinformatics Analysis and In Vitro Assay8
Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway8
Combination Therapy with Androgen Receptor Pathway Inhibitors for Prostate Cancer8
A Novel Oncogenic Role of Disulfidptosis-related Gene SLC7A11 in Anti-tumor Immunotherapy Response to Human Cancers8
Drug-Induced Peripheral Neuropathy: Diagnosis and Management7
GRP78 is Overexpressed in Non-small Cell Lung Cancer Tissues and is Associated with High VEGF Expression in Squamous Cell Carcinoma: A Pilot Study7
Acknowledgement to Reviewers7
Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications7
Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent7
Expression, Prognostic Value, and Immune Infiltration of MTHFD Family in Bladder Cancer7
Hybrid Nanoparticle for Co-delivering Paclitaxel and Dihydroartemisinin to Exhibit Synergic Anticancer Therapeutics7
Rediscovering Potential Molecular Targets for Glioma Therapy Through the Analysis of the Cell of Origin, Microenvironment and Metabolism7
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy7
Anti-Resistant Strategies: Icotinib Derivatives as Promising Non-Small Cell Lung Cancer Therapeutics7
H3K27ac-activated LncRNA NUTM2A-AS1 Facilitated the Progression of Colorectal Cancer Cells via MicroRNA-126-5p/FAM3C Axis7
Comparison of Surgical and Colonoscopy Tissue to Establish Colorectal Patient-derived Organoids6
Development of CDK12 as a Cancer Therapeutic Target and Related Inhibitors6
Establishment and Validation of a Blood Test-based Nomogram to Diagnose Patients with AFP-negative HCC6
The Therapeutic Potential of MAPK/ERK Inhibitors in the Treatment of Colorectal Cancer6
The Therapeutic Potential of Urolithin A for Cancer Treatment and Prevention6
Nanotechnology-enabled Chemodynamic Therapy and Immunotherapy6
The Role of Vasodilator-stimulated Phosphoproteins in the Development of Malignant Tumors6
Identification of ATM Mutation as a Potential Prognostic Biomarker for Immune Checkpoint Inhibitors Therapy6
Anti-Obesity Medications in Cancer Therapy: A Comprehensive Insight6
Comprehensive Analyses and Experiments Confirmed IGFBP5 as a Prognostic Predictor Based on an Aging-genomic Landscape Analysis of Ovarian Cancer6
Unveiling Novel Therapeutic Drug Targets and Prognostic Markers of Triple Negative Breast Cancer6
Clinical Efficacy and Safety of Anlotinib Combined with Immune Checkpoint Inhibitors in the Treatment of Advanced Squamous Cell Lung Cancer: A Retrospective Single-Center Study in China6
WITHDRAWN: Network Pharmacology and In vitro Experiments Reveal that Noscapine Induces Ros-mediated Apoptosis and Cell Cycle Arrest via PI3K/Akt/FoxO3a Signaling Pathway in Human Bladder Cancer Cells6
LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ16
State-of-the-Art: Exosomes in Colorectal Cancer6
LMNB1/CDKN1A Signaling Regulates the Cell Cycle and Promotes Hepatocellular Carcinoma Progression6
Withanone as an Emerging Anticancer Agent and Understanding Its Molecular Mechanisms: Experimental and Computational Evidence6
A Comprehensive Review on Novel Pathways in Cancer Treatment: Clinical Applications and Future Prospects6
FHOD3 Promotes the Progression of Lung Cancer by Regulating the Caspase-3-Mediated Signaling Pathway6
CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells6
Targeting the HIF-1α/Cav-1 Pathway with a Chicory Extract/Daidzein Combination Plays a Potential Role in Retarding Hepatocellular Carcinoma5
Deubiquitylase USP31 Induces Autophagy and Promotes the Progression in Lung Squamous Cell Carcinoma Cells by Stabilizing E2F1 Expression5
Acid Ceramidase, a Double-edged Sword in Cancer Aggression: A Minireview5
Pan-cancer Analysis Confirms the Prognostic and Immunological Effects of Prostate Tumor Overexpressed-1 in Human Cancers5
Bromodomain Protein-directed Agents and MYC in Small Cell Lung Cancer5
CNDP1 Suppresses the Malignant Behavior of Hepatoma Cell via Restricting PI3K-AKT-mTOR Activation5
Fe3O4-viral-like Mesoporous Silica Nanoparticle(Fe3O4-vMSN)-Sustained Release of Lenvatinib for Targeted Treatment of Hepatocellular Carcinoma5
Review Deciphering the Potential of Nanotherapeutics in Lung Cancer Management5
Interrupted Crosstalk between Natural Killer Cells and Anti-epidermal Growth Factor Receptor: A Possible Role in Hepatocellular Carcinoma Treatment Failure5
ZIP14 Affects the Proliferation, Apoptosis, and Migration of Cervical Cancer Cells by Regulating the P38 MAPK Pathway5
Cuproptosis Related Gene DLD Associated with Poor Prognosis and Malignant Biological Characteristics in Lung Adenocarcinoma5
Localized Nano-mediated Interleukin-12 Gene Therapy: Promising Candidate for Cancer Immunotherapeutics5
A Review on Patient-derived 3D Micro Cancer Approach for Drug Screen in Personalized Cancer Medicine5
miRNA as Regulators of Prostate Carcinogenesis and Endocrine and Chemoresistance5
Nanotechnological Advancements for the Theranostic Intervention in Anaplastic Thyroid Cancer: Current Perspectives and Future Direction5
The Effects of Mesenchymal Stem Cells Loaded with Oncolytic Coxsackievirus A21 on Mouse Models of Colorectal Cancer5
The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance5
SELENBP1 Inhibits the Warburg Effect and Tumor Growth by Reducing the HIF1α Expression in Colorectal Cancer5
The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer5
TBOPP, a DOCK1 Inhibitor, Potentiates Cisplatin Efficacy in Breast Cancer by Regulating Twist-mediated EMT5
Biomacromolecule-Functionalized Nanoparticle-Based Conjugates for Potentiation of Anticancer Therapy5
Downregulation of CCKBR Expression Inhibits the Proliferation of Gastric Cancer Cells, Revealing a Potential Target for Immunotoxin Therapy4
Acknowledgement to Reviewers4
Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues4
Illuminating the Role of Wound Healing-Related Hub Genes in Colorectal Adenocarcinoma: Molecular Mechanisms, Prognostic Implications, and Therapeutic Potential4
DTL is a Novel Downstream Gene of E2F1 that Promotes the Progression of Hepatocellular Carcinoma4
UCA1 Inhibits NKG2D-mediated Cytotoxicity of NK Cells to Breast Cancer4
Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance4
Research Progress of Neural Invasion in Pancreatic Cancer4
Vitamin B12 Protects against Genotoxicity Induced by Cisplatin4
The Interactions among Hypertension, Cancer, and COVID-19: Perspective with Regard to Ca2+/cAMP Signalling4
The Mad2-Binding Protein p31comet as a Potential Target for Human Cancer Therapy4
Combination of Cefotaxime and Cisplatin Specifically and Selectively Enhances Anticancer Efficacy in Nasopharyngeal Carcinoma4
Epigallocatechin-3-gallate Induced HepG2 Cells Apoptosis through ROSmediated AKT /JNK and p53 Signaling Pathway4
Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner4
PLCG2, A Regulator of Lung Adenocarcinoma Proliferation and Migration Associated with Immune Infiltration4
EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion via Activation of PI3K/AKT and MEK/ERK Signaling4
Inorganic Phosphate (Pi) in the Breast Cancer Microenvironment: Production, Transport and Signal Transduction as Potential Targets for Anticancer Strategies4
High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the Progression of Osteosarcoma via the NF-κB Pathway in MG63 Cells4
The Clinical Role of Hypoxia Inducible Factor (HIF) Inhibition in Renal Cancer: A Focus on Belzutifan4
MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer Types4
Role of Natural Nuclear Factor Erythroid-2-related Factor 2 (Nrf2) Activators in Oral and Head and Neck Cancer Treatment4
Benzotriazole Substituted 2-Phenylquinazolines as Anticancer Agents: Synthesis, Screening, Antiproliferative and Tubulin Polymerization Inhibition Activity4
Research Advances of Clinical Application of Oncolytic Viruses in Treatment of Gynecologic Cancers4
IL-33/ST2 Signaling and its Correlation with Macrophage Heterogeneity and Clinicopathologic Features in Human Intrahepatic Cholangiocarcinoma4
Synthesis and Preliminary Evaluations of [18F]fluorinated Pyridine-2- carboxamide Derivatives for Targeting PD-L1 in Cancer4
Exosomes Mediate the Production of Oxaliplatin Resistance and Affect Biological Behaviors of Colon Cancer Cell Lines3
Successful Treatment of Switching EGFR-TKIs for Advanced Lung Adenocarcinoma Due to Interstitial Lung Disease: A Case Report3
Dietary Flavonoids with Catechol Moiety Inhibit Anticancer Action of Bortezomib: What about the other Boronic Acid-based Drugs?3
Probiotics as a Therapeutic Approach in Colorectal Cancer3
Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and Metastasis3
The Therapeutic Potential of Targeting Tumor Microenvironment and Modulation of Immunotherapy in Gastrointestinal Cancer3
Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer3
Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance3
Use of Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy For Spindle Cell Carcinoma of the Breast: A Case Report3
Network Pharmacology-Based Virtual Screening of Chemical Constituents from Vitexnegundo Linn’s Discovered Novel Molecular Targets for Breast Cancer Treatment3
Denosumab Induces Neoplastic Stromal Cell Apoptosis Via p62 Downregulation Dependent on Autophagy Pathway in Giant Cell Tumour of Bone3
Forkhead-box A3 (FOXA3) Represses Cancer Stemness and Partially Potentiates Chemosensitivity by Targeting Metastasis-Associated in Colon Cancer 1 (MACC1) Signaling Pathway in Colorectal Cancer Cells3
The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer3
Molecular Targets and Nano-Technological Approaches in the Treatment of Hepatic Carcinoma3
A Phase II Clinical Study on Apatinib Plus Vinorelbine in Refractory HER2-Negative Breast Cancer and its Metabolic Implications of Drug Resistance3
PPT1 Promotes Growth and Inhibits Ferroptosis of Oral Squamous Cell Carcinoma Cells3
MMP7, Regulated by c-Jun, is Involved in Oral Squamous Cell Carcinoma and Associated with Cancer-Related Fibroblasts Infiltration3
Prognostic Significance and Functional Mechanism of UTS2 in Glioblastoma Multiforme3
Low Expression of SCN4B Predicts Poor Prognosis in Non-Small Cell Lung Cancer3
MALAT1 as a Versatile Regulator of Cancer: Overview of the Updates from Predatory Role as Competitive Endogenous RNA to Mechanistic Insights3
Receptor Type Protein Tyrosine Phosphatase Epsilon (PTPRE) Plays an Oncogenic Role in Thyroid Carcinoma by Activating the AKT and ERK1/2 Signaling Pathway3
Dysregulated Epigenetics of Chordoma: Prognostic Markers and Therapeutic Targets3
MiR-129-5p Promotes Radio-sensitivity of NSCLC Cells by Targeting SOX4 and RUNX13
Polycaprolactone-based Nanocarriers Containing 5-fluorouracil as a Therapeutic Guided Drug Delivery Approach for Enhancing Anticancer Activity3
Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy3
The Role of Bile Acids in Pancreatic Cancer3
Targeting the Tumor Epigenetic Regulator SETDB1 for Tumor Therapy3
Modulation of Matrix Metalloproteinases by Plant-derived Products2
MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy2
Resistance of Lenvatinib in Hepatocellular Carcinoma2
Characteristic Hallmarks of Aging and the Impact on Carcinogenesis2
Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple Mechanisms2
Forkhead Box Protein M1 (FOXM1): Prospective Prognostic Biomarker and Therapeutic Targets in Oral Cancer2
Potential Therapeutic Strategies for Targeting Y-Box-Binding Protein 1 in Cancers2
Regulating Tumorigenicity and Cancer Metastasis through TRKA Signaling2
New Carbothioamide and Carboxamide Derivatives of 3-Phenoxybenzoic Acid as Potent VEGFR-2 Inhibitors: Synthesis, Molecular Docking, and Cytotoxicity Assessment2
Targeted Biological Effect of An Affitoxin Composed of an HPV16E7 Affibody Fused with Granzyme B (ZHPV16E7-GrB) Against Cervical Cancer In vitro and In vivo2
Immunotherapy for Gastroesophageal Tumors: Is there still Hope for Efficacy?2
Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma: Disrupting the Tumor-stromal Cross-talk, Next Hope on the Horizon?2
Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies2
Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL)2
Growth-hormone-releasing Hormone as a Prognostic Biomarker and Therapeutic Target in Gastrointestinal Cancer2
A Potential Role for Oridonin in Cancer Control: Mechanisms of Autophagy and Apoptosis2
An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer2
Exploring the Antitumor Efficacy of PEGylated Liposomes Loaded with Licorice Extract for Cancer Therapy2
The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-Analysis2
DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC2
RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARP Inhibitors2
The Epigenetic Factors that Drive Cancer Drug Resistance2
Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis2
HDAC4-mediated Deacetylation of Glutaminase Facilitates Glioma Stemness2
Knockdown of ARL5B Induces Mitochondrial-mediated Apoptosis and Inhibits Glycolysis in Breast Cancer Cells by Activating MDA5 Signaling2
LINC00461 Knockdown Enhances the Effect of Ixazomib in Multiple Myeloma Cells2
A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer2
Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids2
The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer2
IR-780 Dye-based Targeting of Cancer-associated Fibroblasts Improves Cancer Immunotherapy by Increasing Intra-tumoral T Lymphocytes Infiltration2
VX-765 has a Protective Effect on Mice with Ovarian Injury Caused by Chemotherapy2
The Mutation and Low Expression of ARID1A are Predictive of a Poor Prognosis and High Immune Infiltration in Triple-negative Breast Cancer2
Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin2
Construction of an Oxidative Stress Risk Model to Analyze the Correlation Between Liver Cancer and Tumor Immunity2
Overexpression of BRD4 in Gastric Cancer and its Clinical Significance as a Novel Therapeutic Target2
SULF1 Activates the VEGFR2/PI3K/AKT Pathway to Promote the Development of Cervical Cancer2
Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy2
CEA-regulated Oncolytic Virus Anticancer Therapy: A Promising Strategy for Rare Solid Tumors2
Antibody-drug Conjugate Targets, Drugs, and Linkers2
Value of Label-Free Ubiquitin-Proteomic Analysis on Defining the Protective Mechanism of Valsartan against Doxorubicin-Induced Heart Failure1
The Influence of KIR Gene Polymorphisms and KIR-ligand Binding on Outcomes in Hematologic Malignancies following Haploidentical Stem Cell Transplantation: A Comprehensive Review1
Envafolimab Inhibits the Growth of Gastric Cancer Cells with Low PD-L1 Expression through the DDX20/NF-κB/TNF-α Signaling Pathway1
Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer1
PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors1
Protein Tyrosine Phosphatase 1B (PTP1B): Insights into its New Implications in Tumorigenesis1
VE-822 Enhanced Cisplatin Chemotherapy Effects on Head and Neck Squamous Cell Carcinoma Drug-resistant Cells1
The Clinicopathological and Prognostic Significance of the Expression of PD-L1 and MET Genes in Breast Cancer: Potential Therapeutic Targets1
Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives1
The DNMT3B Inhibitor Nanaomycin A as a Neuroblastoma Therapeutic Agent1
Geiparvarin Inhibits the Progression of Osteosarcoma by Down-regulating COX2 Expression1
WITHDRAWN: Hidrosmin Attenuates Inflammatory Response Induced by IL1β by Suppressing the Activation of NF-κB Involving Nrf2/HO1 Pathway in Human Osteoarthritis Chondrocytes1
Ligand-mediated Targeted Drug Delivery Approaches against Hepatocellular Carcinoma1
Neomorphic IDH Heterodimer Mutants: An Underestimated Point in Cancer Pathogenesis1
Impact of GSTT1 and GSTM1 Polymorphisms in the Susceptibility to Philadelphia Negative Chronic Myeloid Leukaemia1
Association of Polymorphism in Survivin Gene and the Risk of Liver Cancer Resulting from Hepatitis C Virus Among Egyptian Patients1
Molecular Mechanism and Research Progress of Sphingolipid Metabolism in Regulating Radiation-induced Apoptosis Using Pan-cancer Analysis1
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma1
The COX-2 Inhibitor Celecoxib Sensitizes Nasopharyngeal Carcinoma Cells to Ferroptosis1
Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway1
Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic Cancer1
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis1
Transforming Cancer Care: The Impact of AI-driven Strategies1
AHNAK2 Promotes the Progression of Differentiated Thyroid Cancer through PI3K/AKT Signaling Pathway1
Current Treatment and Future Trends of Immunotherapy in Breast Cancer1
Mitochondrial Calcium Uniporter (MCU) that Modulates Mitochondrial Calcium Uptake and Facilitates Endometrial Cancer Progression through Interaction with VDAC11
Role of Exosomes in Breast Cancer Management: Evidence-Based Review1
Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic Study1
Preface1
Cancer and Autoimmune Diseases as Two Sides of Chronic Inflammation and the Method of Therapy1
Polyphyllin VII is a Potential Drug Targeting CD44 Positive Colon Cancer Cells1
NONO-TFE3 Fusion Promotes Aerobic Glycolysis and Angiogenesis by Targeting HIF1A in NONO-TFE3 Translocation Renal Cell Carcinoma1
Novel Synergistic Combination of Pamidronate and Temozolomide for Breast Cancer Therapeutics1
Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients1
Preventive and Therapeutic effects of Metformin in Cancer: A Meta-Analysis of RCT and Cohort Studies1
Withaferin A Inhibits Liver Cancer Tumorigenesis by Suppressing Aerobic Glycolysis through the p53/IDH1/HIF-1α Signaling Axis1
Complement Factor H Promotes the Growth of Lung Adenocarcinoma Cells through the JAK2/STAT3 Signaling Pathway1
Cuproptosis: Mechanism and Application in Lymphoma1
WITHDRAWN: Comprehensive Analysis of the Role of CXCL Family Members in Clear Cell Renal Cell Carcinoma1
Pharmacological Inhibition of Exosome Machinery: An Emerging Prospect in Cancer Therapeutics1
Magnesium as a Co-Factor: A Vital Cation with Pro- and Anti-Tumor Effects1
Transcription Factor MAZ Potentiates the Upregulated NEIL3-mediated Aerobic Glycolysis, thereby Promoting Angiogenesis in Hepatocellular Carcinoma1
Present and Future Prospects of the Anti-cancer Activities of Saikosaponins1
Disulfiram-Copper Potentiates Anticancer Efficacy of Standard Chemo-therapy Drugs in Bladder Cancer Animal Model through ROS-Autophagy-Ferroptosis Signalling Cascade1
Modulation of ATP8B1 Gene Expression in Colorectal Cancer Cells Suggest its Role as a Tumor Suppressor1
CDK-associated Cullin 1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Human Glioblastoma1
BCL11A Facilitates Cell Proliferation and Metastasis in Neuroblastoma via Regulating the PI3K/Akt Signaling Pathway1
The Efficacy and Safety of Inetetamab and Pyrotinib in Combination with Vinorelbine for Second-line Therapy and Beyond in HER2-positive Metastatic Breast Cancer: A Single-institution Clinical Experien1
Cholangiocarcinoma Therapeutics: An Update1
A Pan-cancer Analysis to Determine the Prognostic Analysis and Immune Infiltration of HSPA51
Advancement and Strategies for the Development of Peptide-drug Conjugates: Pharmacokinetic Modulation, Role and Clinical Evidence against Cancer Management1
Role of Aberrant Lipid Metabolism of Cancer Stem Cells in Cancer Progression1
Insight into the Basic Mechanisms and Various Modulation Strategies Involved in Cancer Drug Resistance1
0.092307090759277